Purpose and Scope:
The specialist in Labeling and Artwork management is responsible for the creation, revision and management of artwork for specific area(s) or product(s).
Responsibilities and Accountabilities:
- Execute artwork revision works as planned in for specific area(s) or product(s)
- Manage the execution of artwork development and maintenance with relevant multidisciplinary teams and/or customers according to the effective SOP’s.
- Manages end-to-end artwork change using knowledge of regulatory processes, Supply Chain and production environments.
- Manage and control priority within own product portfolio ensuring stable supply of product.
- Contribute to cross functional process; Change control of Text and/or Artwork (CCTA), SPD Change control, CMC.
- Support and contribute product launch and product life cycle projects for LMG related activities.
- Support of training, document control and deviations
- Support necessary business process and systems for LMG such as; Artwork Management System, Agency management and data management.
Required Qualifications:
- Experience for >2 years with Artwork process, change control in GMP environment or equivalent expertise in eg: RA, QA, supply chain and manufacturing (GxP oriented)
- Education: bachelor’s degree or equivalent
- Cross-functional collaboration skills, able to build friendly cooperative relationships with surroundings (including external parties)
- Good knowledge and understanding packaging printing environment
Working Environment
Astellas’ Global Capability Centres (GCCs) are strategically located sites that give Astellas the ability to access talent across various functions in the value chain and to co-locate core capabilities that are currently dispersed. Our three GCCs are located in India, Poland and Mexico.
The GCCs will enhance our operational efficiency, resilience and innovation potential, enabling a timely response to changing business demands.
Our GCCs are an integral part of Astellas, guided by our shared values and behaviors, and are critical enablers of the company’s strategic priorities, sustainable growth, and commitment to turn innovative science into VALUE for patients.
